Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 3—March 2011
Research

Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009

Bianca R. PerriComments to Author , Douglas C. Proops, Patrick K. Moonan, Sonal S. Munsiff, Barry N. Kreiswirth, Natalia Kurepina, Christopher Goranson, and Shama D. Ahuja
Author affiliations: Author affiliations: New York City Department of Health and Mental Hygiene, New York, New York, USA (B.R. Perri, D. Proops, S.S. Munsiff, C. Goranson, S.D. Ahuja); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.R. Perri, P.K. Moonan, S.S. Munsiff); Public Health Research Institute Tuberculosis Center, Newark, New Jersey, USA (B.N. Kreiswirth, N. Kurepina)

Main Article

Table

Characteristics of 54 TB patients, by drug susceptibility test results, New York, New York, USA, 2003–2009*

Characteristic All patients Type of Mycobacterium tuberculosis
 p value
Drug-susceptible, n = 37 Isoniazid-resistant, n = 17
Median age at TB diagnosis, y (range) 41 (10–77) 42 (12–77) 39 (10–52) 0.12
Male sex
 37 (69)
 27 (73)
 10 (59)
 0.30
Race/ethnicity
Asian 1 (2) 1 (3) 0 1.00†
Hispanic 13 (24) 8 (22) 5 (29) 0.73†
Black, non-Hispanic
 40 (74)
 28 (76)
 12 (71)
 0.74†
Country of origin
United States 36 (67) 22 (59) 14 (82) 0.10
Foreign 17 (31) 14 (38) 3 (18) 0.14
Unknown
 1 (2)
 1 (3)
 0
 1.00†
History of illegal drug use‡ 22 (41) 12 (32) 10 (59) 0.07
History of homelessness 13 (24) 8 (22) 5 (29) 0.73†
History of incarceration
 12 (22)
 4 (11)
 8 (47)
 <0.01†
Pulmonary site of TB§ 48 (89) 32 (87) 16 (94) 0.65†
Cavitary (among cases with pulmonary site of disease) 12 (25) 7 (22) 5 (31) 0.50†
Acid-fast bacilli smear positive for respiratory specimen
 38 (70)
 24 (65)
 14 (82)
 0.19
HIV status
Positive 14 (26) 9 (24) 5 (29) 0.74†
Negative 37 (69) 26 (70) 11 (65) 0.68
Unknown 3 (6) 2 (5) 1 (6) 1.00†

*Values are no. (%) unless otherwise indicated. TB, tuberculosis.
†By Fisher exact test.
‡Use of injection (e.g., heroin) or noninjection (e.g., marijuana or cocaine) drugs indicated on any patient record.
§Includes patients with only pulmonary sites of disease and patients with pulmonary and extrapulmonary sites of disease.

Main Article

Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external